| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |